Intrinsic value of Pasithea Therapeutics Corp. (KTTA)
Live fair value data for Pasithea Therapeutics Corp. (KTTA) is currently unavailable. Please check again shortly.
Current Price: $198.00
Valuation: Overvalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Pasithea Therapeutics Corp. (KTTA) undervalued or overvalued?
Based on the current model output, Pasithea Therapeutics Corp. appears to be overvalued with a downside of 19.00%.
Fair value vs market price — Pasithea Therapeutics Corp. (KTTA)
Unlock premium access to view the live fair value comparison against current market price for KTTA.
Frequently Asked Questions - KTTA
How is KTTA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for KTTA.
Is KTTA undervalued or overvalued right now?
KTTA is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for KTTA: open their intrinsic value pages.